164 related articles for article (PubMed ID: 17888148)
1. The HIV RNA setpoint theory revisited.
Geskus RB; Prins M; Hubert JB; Miedema F; Berkhout B; Rouzioux C; Delfraissy JF; Meyer L
Retrovirology; 2007 Sep; 4():65. PubMed ID: 17888148
[TBL] [Abstract][Full Text] [Related]
2. AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: markers with reciprocal predictive value over time after seroconversion.
de Wolf F; Spijkerman I; Schellekens PT; Langendam M; Kuiken C; Bakker M; Roos M; Coutinho R; Miedema F; Goudsmit J
AIDS; 1997 Dec; 11(15):1799-806. PubMed ID: 9412697
[TBL] [Abstract][Full Text] [Related]
3. Viral load and CD4 count dynamics after HIV-1 seroconversion in homosexual and bisexual men in Rio de Janeiro, Brazil.
Djomand G; Duerr A; Faulhaber JC; Struchiner CJ; Pacheco AG; Barroso PF; Melo MF; Schechter M
J Acquir Immune Defic Syndr; 2006 Dec; 43(4):401-4. PubMed ID: 17031316
[TBL] [Abstract][Full Text] [Related]
4. Body mass index course in asymptomatic HIV-infected homosexual men and the predictive value of a decrease of body mass index for progression to AIDS.
Maas JJ; Dukers N; Krol A; van Ameijden EJ; van Leeuwen R; Roos MT; de Wolf F; Coutinho RA; Keet IP
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):254-9. PubMed ID: 9803967
[TBL] [Abstract][Full Text] [Related]
5. Association of HLA profiles with early plasma viral load, CD4+ cell count and rate of progression to AIDS following acute HIV-1 infection. Multicenter AIDS Cohort Study.
Saah AJ; Hoover DR; Weng S; Carrington M; Mellors J; Rinaldo CR; Mann D; Apple R; Phair JP; Detels R; O'Brien S; Enger C; Johnson P; Kaslow RA
AIDS; 1998 Nov; 12(16):2107-13. PubMed ID: 9833851
[TBL] [Abstract][Full Text] [Related]
6. Time-updated CD4+ T lymphocyte count and HIV RNA as major markers of disease progression in naive HIV-1-infected patients treated with a highly active antiretroviral therapy: the Aquitaine cohort, 1996-2001.
Thiébaut R; Chêne G; Jacqmin-Gadda H; Morlat P; Mercié P; Dupon M; Neau D; Ramaroson H; Dabis F; Salamon R;
J Acquir Immune Defic Syndr; 2003 Jul; 33(3):380-6. PubMed ID: 12843750
[TBL] [Abstract][Full Text] [Related]
7. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.
Hogg RS; Yip B; Chan KJ; Wood E; Craib KJ; O'Shaughnessy MV; Montaner JS
JAMA; 2001 Nov; 286(20):2568-77. PubMed ID: 11722271
[TBL] [Abstract][Full Text] [Related]
8. Low T-cell responses to CD3 plus CD28 monoclonal antibodies are predictive of development of AIDS.
Roos MT; Prins M; Koot M; de Wolf F; Bakker M; Coutinho RA; Miedema F; Schellekens PT
AIDS; 1998 Oct; 12(14):1745-51. PubMed ID: 9792374
[TBL] [Abstract][Full Text] [Related]
9. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
Sterling TR; Vlahov D; Astemborski J; Hoover DR; Margolick JB; Quinn TC
N Engl J Med; 2001 Mar; 344(10):720-5. PubMed ID: 11236775
[TBL] [Abstract][Full Text] [Related]
10. CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus.
Ghosn J; Bayan T; Meixenberger K; Tran L; Frange P; d'Arminio Monforte A; Zangerle R; de Mendoza C; Krastinova E; Porter K; Meyer L; Chaix ML;
J Antimicrob Chemother; 2017 Oct; 72(10):2862-2868. PubMed ID: 29091208
[TBL] [Abstract][Full Text] [Related]
11. CD4+ cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, sex and calendar time.
Cori A; Pickles M; van Sighem A; Gras L; Bezemer D; Reiss P; Fraser C
AIDS; 2015 Nov; 29(18):2435-46. PubMed ID: 26558543
[TBL] [Abstract][Full Text] [Related]
12. Lack of evidence for changing virulence of HIV-1 in North America.
Herbeck JT; Gottlieb GS; Li X; Hu Z; Detels R; Phair J; Rinaldo C; Jacobson LP; Margolick JB; Mullins JI
PLoS One; 2008 Feb; 3(2):e1525. PubMed ID: 18253479
[TBL] [Abstract][Full Text] [Related]
13. Surrogate markers for disease progression in treated HIV infection.
Ghani AC; de Wolf F; Ferguson NM; Donnelly CA; Coutinho R; Miedema F; Goudsmit J; Anderson RM
J Acquir Immune Defic Syndr; 2001 Nov; 28(3):226-31. PubMed ID: 11694828
[TBL] [Abstract][Full Text] [Related]
14. Early and late HIV-1 RNA level and its association with other markers and disease progression in long-term AIDS-free homosexual men.
Spijkerman IJ; Prins M; Goudsmit J; Veugelers PJ; Coutinho RA; Miedema F; de Wolf F
AIDS; 1997 Sep; 11(11):1383-8. PubMed ID: 9302449
[TBL] [Abstract][Full Text] [Related]
15. Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy.
Potter M; Odueyungbo A; Yang H; Saeed S; Klein MB;
AIDS; 2010 Jul; 24(12):1857-65. PubMed ID: 20479633
[TBL] [Abstract][Full Text] [Related]
16. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand.
Wannamethee SG; Sirivichayakul S; Phillips AN; Ubolyam S; Ruxrungtham K; Hanvanich M; Phanuphak P
Int J Epidemiol; 1998 Apr; 27(2):289-95. PubMed ID: 9602412
[TBL] [Abstract][Full Text] [Related]
17. Persistent immune activation in HIV-1 infection is associated with progression to AIDS.
Hazenberg MD; Otto SA; van Benthem BH; Roos MT; Coutinho RA; Lange JM; Hamann D; Prins M; Miedema F
AIDS; 2003 Sep; 17(13):1881-8. PubMed ID: 12960820
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy.
Sterling TR; Chaisson RE; Moore RD
AIDS; 2001 Nov; 15(17):2251-7. PubMed ID: 11698698
[TBL] [Abstract][Full Text] [Related]
19. Comparison of prognostic importance of latest CD4+ cell count and HIV RNA levels in patients with advanced HIV infection on highly active antiretroviral therapy.
MacArthur RD; Perez G; Walmsley S; Baxter JD; Mullin CM; Neaton JD; ;
HIV Clin Trials; 2005; 6(3):127-35. PubMed ID: 16192247
[TBL] [Abstract][Full Text] [Related]
20. Effect of incident hepatitis C infection on CD4+ cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort.
van Santen DK; van der Helm JJ; Touloumi G; Pantazis N; Muga R; Gunsenheimer-Bartmeyer B; Gill MJ; Sanders E; Kelleher A; Zangerle R; Porter K; Prins M; Geskus RB;
AIDS; 2019 Feb; 33(2):327-337. PubMed ID: 30325767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
